| Status | Update | Ingredients | Specialty |
| Out of stock | Jan. 3, 2025 | ondansetron | Zophren 2 mg/ml, solution for injection in ampoule (IV) (box 1 ampoule of 4 ml) – |
| Supply tension | Jan. 3, 2025 | bevacizumab | Aybintio 25 mg/ml, solution to be diluted for infusion (16 ml bottle) – |
| Availability | Jan. 2, 2025 | somatropin | Norditropin Flexpro 5 mg/1.5 ml, solution for injection in pre-filled pen – |
| Supply tension | Jan. 2, 2025 | peginterferon alfa-2a | Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – |
| Out of stock | 31-Dec-24 | carmustine | Gliadel 7.7 mg, implant – |
| Supply tension | 31-Dec-24 | somatotropin | Genotonorm 12 mg, powder and solvent for solution for injection box of 5 cartridges in GoQuick pre-filled pen – |
| Supply tension | Dec. 31, 2024 | ondansetron | Ondansetron Viatris 2 mg/ml, solution for injection (I.V.) – |
| Out of stock | Dec. 30, 2024 | fluorouracil | Fluorouracil Teva 50 mg/ml, solution for diluted infusion, 100 ml bottle – |
| Remise à disposition | Dec. 30, 2024 | captopril | Noyada 25 mg/5 ml, oral solution – |
| Supply tension | Dec. 30, 2024 | basiliximab (mammal/mouse/Sp2/O) | Simulect 20 mg, powder and solvent for solution for injection or infusion – |
| Supply tension | Dec. 30, 2024 | tropicamide | Mydriaticum 2 mg/0.4 ml, eye drops in single-dose container – |
2025年1月6日